^
    over1year
    Clinical Trial of PM54 in Advanced Solid Tumors Patients. (clinicaltrials.gov)
    P1, N=125, Recruiting, PharmaMar
    New P1 trial
    |
    BRAF (B-raf proto-oncogene) • BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset)
    |
    HER-2 positive • BRCA2 mutation • BRCA1 mutation • HR positive • BRAF mutation • BRAF wild-type
    |
    PM54